Search

Carlsmed Raises $2.5M to Improve Complex Spine Surgery

Carlsmed, Inc., a San Diego-based MedTech company, today announced the close of an oversubscribed $2.5M seed round. The round was led by Cove Fund II, a prominent California Life Science and Technology fund. Participating in the round are MedTech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.


CONTINUE READING

Recent Posts

See All

301 North Lake Avenue, Suite 930, Pasadena, CA 91101       funding@wavemaker360.com

© 2020 Wavemaker Three-Sixty Health